Effectiveness and Safety of Transurethral Needle Ablation for Benign Prostatic Hyperplasia
Author Information
Author(s): Bouza Carmen, López Teresa, Magro Angeles, Navalpotro Lourdes, Amate José María
Primary Institution: Agency for Health Technology Assessment, Ministry of Health & Consumers Affairs, Madrid, Spain
Hypothesis
What is the efficacy and safety of Transurethral Needle Ablation (TUNA) in treating symptomatic Benign Prostatic Hyperplasia (BPH)?
Conclusion
TUNA significantly improves BPH parameters compared to baseline values, but it is less effective and has a higher re-treatment rate than TURP.
Supporting Evidence
- TUNA significantly improves BPH parameters with respect to baseline values.
- TUNA has a higher re-treatment rate compared to TURP.
- TUNA shows a lower rate of complications than TURP.
- TUNA requires fewer anesthetic resources and results in shorter hospital stays than TURP.
Takeaway
TUNA is a procedure that helps men with prostate problems feel better, but it doesn't work as well as the standard surgery and some men may need more treatment later.
Methodology
Systematic review and meta-analysis of clinical studies assessing TUNA in symptomatic BPH.
Potential Biases
Potential publication bias and methodological biases in included studies.
Limitations
The body of evidence is of moderate-low quality, with limited data on long-term efficacy and safety.
Participant Demographics
Patients with symptomatic BPH, mean age 67.5 years.
Statistical Information
P-Value
<0.05
Confidence Interval
95% CI: 18.7–39.7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website